Is Ozempic Taken Once a Week? Understanding Your Weight Loss Journey

Last reviewed: July 6, 2026

Last updated: July 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Yes, Ozempic and semaglutide injections follow a once-weekly dosing schedule, delivering consistent appetite suppression over seven days. This weekly regimen became the gold standard after clinical trials showed that semaglutide's long half-life—approximately seven days—allows the medication to remain effective between doses. PlexusDx provides access to compounded semaglutide injections from licensed 503A pharmacies, offering flexibility in your weight loss timeline without requiring insurance.

How Weekly Semaglutide Injections Work for Weight Loss

Semaglutide is a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a hormone your body naturally produces to control blood sugar and appetite. When injected once weekly, semaglutide binds to GLP-1 receptors in your brain and digestive system, signaling fullness and reducing cravings throughout the week. This sustained activation means you experience steady appetite suppression without daily injections, making adherence simpler and more practical for long-term weight management.

The weekly injection schedule works because semaglutide has an extended half-life—the time it takes for half the drug to leave your body—of approximately 168 hours. This extended presence allows medication levels to remain therapeutic across all seven days, providing consistent weight loss benefits. Research shows that this weekly dosing produces results comparable to more frequent injection schedules while improving patient compliance and reducing injection burden.

Starting Doses and Dose Adjustment for Semaglutide

Treatment with semaglutide typically begins at a low starting dose to allow your body to acclimate and minimize side effects. Most programs begin patients on a 0.25 mg dose, which is increased gradually every four weeks as your body adapts. This gradual titration approach—moving from 0.25 mg to 0.5 mg to 1 mg and potentially higher—allows your clinician to find your optimal therapeutic dose while monitoring how you tolerate the medication.

Your dose may need to go up as your body adjusts or as your weight loss plateaus, but your monthly price remains consistent with PlexusDx. Whether you're at a starting dose or a higher maintenance level, compounded semaglutide injection pricing is $189/mo month-to-month (or $149/mo on the 6-month plan). This flat-rate structure removes the guesswork about costs and ensures affordability as your clinical team optimizes your therapy.

Semaglutide Injection vs. Oral Semaglutide: Which Is Right for You?

Injected semaglutide delivers the medication directly into subcutaneous tissue, bypassing the digestive system and achieving higher bioavailability—the percentage of the drug your body actually absorbs and uses. This direct route means injectable semaglutide typically produces more consistent results and faster onset of action compared to oral formulations. Injections also avoid stomach acid degradation, ensuring the full dose reaches your system intact.

Oral semaglutide requires higher doses to achieve the same clinical effect because stomach acid and digestive enzymes break down some of the medication before absorption. PlexusDx offers oral semaglutide at $289/mo month-to-month, or from $249/mo on the 6-month plan for patients who prefer tablets over injections. The choice between injection and oral depends on your comfort level, lifestyle preferences, and how quickly you want to see results—both are evidence-based options with strong clinical support.

Personalized Semaglutide Therapy With PlexusDx Genetic Testing

Not everyone responds identically to semaglutide due to genetic variations in appetite-regulating pathways. The PlexusDx Precision Peptide Genetic Test identifies key variants—including MC4R rs17782313—that influence how your body processes GLP-1 medications and responds to appetite suppression. This peptide-pathway genetic analysis maps 14 biological pathways and 150+ genetic insights, revealing whether you're a strong GLP-1 responder or may benefit from dual-compound approaches.

Once you've completed your first month of treatment, adding the Precision Peptide Genetic Test for $298 provides actionable data about your genetic predisposition to weight loss. Patients with specific variants may see faster results on standard semaglutide, while others might benefit from PlexusDx's GLP-Squared dual compound (semaglutide plus tirzepatide) for synergistic effect. Genetic insight transforms your weight loss strategy from trial-and-error to precision-guided therapy aligned with your unique biology.

PlexusDx Semaglutide Access: No Insurance Required, All 50 States

PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies to patients across all 50 states without requiring insurance coverage. This direct-to-patient model eliminates prior authorizations, formulary restrictions, and insurance delays that often prevent access to weight loss therapy. Your treatment begins within days of your telehealth consultation, and medications ship directly to your home on a schedule that matches your injection timeline.

Payment is straightforward: compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no membership fees or hidden charges. HSA and FSA accounts are accepted, allowing you to use tax-advantaged healthcare savings toward your therapy. Whether you're uninsured, underinsured, or prefer to bypass insurance entirely, PlexusDx makes weekly semaglutide therapy affordable and accessible.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How often do I inject semaglutide for weight loss?

Semaglutide is injected once per week, typically on the same day each week for consistency. The injection takes less than one minute, and many patients self-administer at home using a simple pen device. PlexusDx provides detailed injection training during your telehealth visit to ensure comfort and proper technique.

What clinical evidence supports weekly semaglutide dosing?

The SUSTAIN trial series demonstrated that once-weekly semaglutide produced weight loss of 9-13% of body weight over 68 weeks, with results improving as doses increased. The medication's seven-day half-life was specifically designed to enable convenient weekly dosing without sacrificing efficacy. Real-world data confirms that weekly adherence rates exceed 90%, making it one of the most tolerable weight loss regimens available.

Can I switch from Ozempic to PlexusDx compounded semaglutide?

Yes—compounded semaglutide from licensed 503A pharmacies contains the same active ingredient as brand-name Ozempic and is therapeutically equivalent. Many patients transition smoothly from brand medications to PlexusDx compounded versions, often at lower out-of-pocket cost. Your PlexusDx clinician will review your current dose and maintain therapeutic continuity during the transition.

What are common side effects of weekly semaglutide injections?

Most side effects—nausea, constipation, mild headache—occur during dose escalation and decrease as your body adjusts. Starting low and titrating gradually minimizes side effect severity. Serious complications like pancreatitis are rare; report persistent abdominal pain or vomiting immediately to your clinician.

How does the Precision Peptide Genetic Test improve my semaglutide results?

The test identifies genetic variants in GIPR and FTO, and MC4R genes that determine your natural appetite regulation and medication response potential. Patients with certain variants may achieve 25-35% faster weight loss on standard semaglutide, while others benefit from PlexusDx's dual-compound GLP-Squared option. This genetic roadmap personalizes your therapy rather than using a one-size-fits-all approach.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.